Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK140676-03
Clinical Impact and Feasibility of Virtual Reality (VR) for Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial Comparing VR Cognitive Behavioral Therapy vs. Sham VR
Recipient
Cedars-Sinai Medical Center
Award Amount
$334,000.00
Ceiling
$334,000.00
Awarded
May 19, 2026
Identifier
5R01DK140676-03
Award for a pilot randomized controlled trial to assess virtual reality cognitive behavioral therapy for irritable bowel syndrome, funded by NIDDK with a $334,000 budget, starting July 2024 and ending April 2027.
Description
This project involves a pilot randomized controlled trial to evaluate the clinical impact and feasibility of a virtual reality-based cognitive behavioral therapy program for irritable bowel syndrome. The award is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, with a total budget of $334,000, and is scheduled to start in July 2024 with a completion date in April 2027.